Inhibitory Control Test for the Diagnosis of Minimal Hepatic Encephalopathy
Overview
Authors
Affiliations
Background & Aims: Minimal hepatic encephalopathy (MHE) is difficult to diagnose. The Inhibitory Control Test (ICT) measures response inhibition and has diagnosed MHE with 90% sensitivity and specificity in a selected population; high lure and low target rates indicated poor ICT performance. We studied the reliability and validity of ICT for MHE diagnosis.
Methods: ICT was compared with a psychometric battery (standard psychometric tests [SPT]) for MHE diagnosis and overt hepatic encephalopathy (OHE) prediction. ICT was administered twice for test-retest reliability, before/after transvenous intrahepatic portosystemic shunting (TIPS), and before/after yogurt treatment. The time taken by 2 medical assistants (MA) to administer ICT was recorded and compared with that of a psychologist for cost analysis.
Results: One hundred thirty-six cirrhotic patients and 116 age/education-matched controls were studied. ICT (>5 lures) had 88% sensitivity for MHE diagnosis with 0.902 area under the curve for receiver operating characteristic. MHE-positive patients had significantly higher ICT lures (11 vs 4, respectively, P = .0001) and lower targets (92% vs 97%, respectively, P = .0001) compared with MHE-negative patients. The test/retest reliability for ICT lures (n = 50, r = 0.90, P = .0001) was high. ICT and SPT were equivalent in predicting OHE (21%). ICT lures significantly worsened after TIPS (n = 10; 5 vs 9, respectively; P = .02) and improved after yogurt supplementation (n = 18, 10 vs 5, respectively; P = .002). The MAs were successfully trained to administer ICT; the time required for test administration and the associated costs were smaller for ICT than for SPT.
Conclusions: ICT is a sensitive, reliable, and valid test for MHE diagnosis that can be administered inexpensively by MAs.
3D printing in anatomical lung segmentectomies: A randomized pilot trial.
Grigoroiu M, Paul J, Brian E, Aegerter P, Boddaert G, Mariolo A Heliyon. 2024; 10(11):e31842.
PMID: 38867971 PMC: 11168317. DOI: 10.1016/j.heliyon.2024.e31842.
Yu S, Chen X Behav Sci (Basel). 2024; 14(3).
PMID: 38540519 PMC: 10968218. DOI: 10.3390/bs14030216.
Bajaj J, Fagan A, Gavis E, Mousel T, Gallagher M, Puri P Hepatol Commun. 2024; 8(2).
PMID: 38315140 PMC: 10843468. DOI: 10.1097/HC9.0000000000000384.
Jinato T, Sikaroodi M, Fagan A, Sterling R, Lee H, Puri P Gut Microbes. 2023; 15(2):2288168.
PMID: 38010871 PMC: 10730154. DOI: 10.1080/19490976.2023.2288168.
Hepatic Encephalopathy following Transjugular Intrahepatic Portosystemic Shunt Placement.
Thornburg B Semin Intervent Radiol. 2023; 40(3):262-268.
PMID: 37484451 PMC: 10359131. DOI: 10.1055/s-0043-1769770.